Call for change in systems biology by Godovac-Zimmermann, J
Professor Jasminka Godovac-Zimmermann is a leading light in proteomics and systems biology. In this interview 
she gives her opinion on where discoveries in these ﬁ elds are leading and the future of scientiﬁ c research in general
Can you begin by outlining your primary 
research interests and what inspired you to 
become an active participant in this fi eld?
From the very beginning my interests have 
focused on the question, 'what is life?' Over 
the years I have reinvented my speciﬁ c 
research interests several times as new tools 
became available, moving from protein 
chemistry to cellular signalling systems to 
proteomics and now increasingly to systems 
biology. For me, proteomics represented a 
natural progression to an area that could 
ask important questions that came after the 
human genome project.
There is still a tendency to expect 
proteomics to fi nd ‘magic-bullet’ genes or 
proteins as targets for the treatment of 
cancer. Is this a realistic expectation?
For a long time now it has been apparent that 
living systems are enormously interconnected 
networks of very large numbers of molecular 
actors. My own opinion is that we should be 
focusing on understanding these networks 
and that, when we do, much more efﬁ cacious 
‘applications’ will become possible. I am 
sceptical that ‘network manipulation’ will be 
based on single molecule ‘magic bullets’.  
If you could select one achievable goal for 
the next decade, what would it be?
The current chaotic, unorganised inputs of 
information seem unlikely to lead to deeper 
understanding. I believe we would make much 
better progress by organising some strong, 
collaborative teams to investigate questions 
like: what is it that makes this particular cell 
system a living object?
This would require some technical 
developments in several ﬁ elds. However, the 
biggest challenges may well be in developing 
appropriate conceptual interpretations, which 
will only become apparent when enormous, 
integrated data sets have been obtained on a 
common, controlled cell system. We should 
note that scientists like Stuart Kauffman have 
pointed out that there are indications that 
living systems may challenge basic ideas, like 
the concept of what entropy really is, and begin 
thoroughly exploring these new ideas. 
The fi eld has experienced exponential growth 
in the last decade? Do you see the pace of 
discovery relenting in the near future?
I believe proteomics needs to grow much 
more and that new technology is still needed. 
Bottom-up proteomics has been essential to 
Biological science in a changing world
THESE ARE EXCITING times for biology, as 
new tools and methods are paving the way 
for scientists to engage with some of the most 
important questions to humanity, such as: 
‘what is life?’ In the 1970s this question had a 
deﬁ nitive working answer and scientists working 
on unmanned exploration missions to Mars and 
other planets knew what to look for. But now, 
with advances in gene sequencing, the creation 
of the ﬁ rst ‘artiﬁ cial’ life, the discovery of the 
‘arsenic bug’ and a more mature understanding 
of cellular and genetic biology, the question is 
being examined in new ways. 
WHAT IS ‘LIFE’?
Proteomics – the large-scale study of the 
functions of proteins, and systems biology 
– holistic research on complex interactions 
in biological systems, are two interrelated 
ﬁ elds that may offer insight into this question 
and others of critical importance to health, 
biotechnology and other ﬁ elds. A leading 
scientist in systems biology and proteomics, 
Jasminka Godovac-Zimmermann is Professor 
of Protein Biochemistry at University College, 
London. She believes that there are a number 
of difﬁ cult questions that these ﬁ elds need to 
answer, such as: “What can we learn about the 
fundamental nature of life by in-depth, large 
scale efforts to characterise the networks and 
network ﬂ uxes that exist in living cells?”
One of the limitations in answering the question 
‘what is life?’ is that proteomics has been 
conditioned by the approaches taken in genomics, 
as Godovac-Zimmermann explains: “Proteomics 
scientists have mainly tended to measure the 
amount of gene-products in a cell. But, at the 
level of ‘what constitutes life’, we already know 
that quantity, form, location, ﬂ uxes and time 
are probably all equally important”. A better 
approach, according to Godovac-Zimmermann, 
is to take a more considered stance: “Where 
proteomics has major conceptual advantages 
and can make vital, unique contributions is in 
measuring the form and location characteristics 
that are not accessible with genomics”. However, 
unique contributions present unique challenges, 
she points out: “The major future challenge for 
proteomics, biology and medicine is no longer in 
cataloguing components of cells or organisms, but 
in elucidating how these components interact to 
constitute living systems”.
IMPORTANT ADVANCES
Another area in which proteomics and 
systems biology are offering valuable 
insight is in the search for cures to some of 
The Molecular Cell Dynamics Group at University College London School of Life & Medical 
Sciences, are leading pioneering research that addresses fundamental questions in systems biology 
and proteomics; work which could represent a paradigm shift from the methods currently employed
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demonstrating the utility of high-throughput 
proteomics, but it tends to mirror the 
genomics quantity approach and discard 
crucial information on form and location of 
cellular proteins. Although, in the near future, 
current proteomic methods will generate 
enormous amounts of data, we also need 
to keep alive a plethora of research groups 
working on developing new technologies that 
will be essential to exploiting the areas where 
proteomics can supply unique information.
In the past you have stated that you believe 
there is a lack of high-quality education for 
young scientists. Is this situation changing?
If students are not provided with a broad 
education that includes fundamental elements of 
many ﬁ elds, they are crippled as future scientists 
in terms of often not even knowing which 
concepts and tools are available. An individual 
cannot be an expert in everything, but he needs 
to know the basic concepts of many ﬁ elds and to 
know which questions to ask of the experts. It is 
a big mistake to narrow education too much to 
speciﬁ c, current, vocational needs of corporations 
or governments, and produce ‘cogs’ that may 
well be obsolete within 10 – 20 years. In the UK, I 
see this situation getting worse, not better.
Increasingly, research institutions are 
feeling the pinch, being asked to streamline 
their research and infrastructure, as well 
as avoiding duplication. Can you tell us 
your thoughts on the effect that the global 
economic downturn is having on research? 
To start with, many of the recent cases of 
scientiﬁ c fraud remind us that duplication 
of studies is a cornerstone of scientiﬁ c 
advancement. No reproducibility, or no parallels 
in similar systems, equals no credibility. To that 
we might add that scientiﬁ c progress often 
seems like ecology: plentiful diversity and 
lots of interactions are needed for systems to 
evolve. So ‘streamlining’, especially if designed 
by politicians or political committees, seems 
likely to be highly counterproductive.
In your opinion, how might the effects of 
cuts be lessened?
If we have to tighten our belts, two guiding 
principles might be useful. First, reverse 
the proﬂ igacy of recent years – cut the 
‘centralised state planning organisations’ that 
impose massive bureaucracy on universities 
and cut at least one central administrative 
position for every academic position lost. 
Second, perhaps we should take note of 
the fact that in some of the world’s most 
successful universities the academics hire and 
ﬁ re the administrators.
the most devastating diseases. Godovac-
Zimmermann and co-workers are looking into 
the possibility of selective killing of cancer 
cells by manipulation of the crucial DNA 
replication licensing process of the mitotic cell 
cycle. A number of cell and molecular biology 
groups have suggested, through speciﬁ c 
point observations, that inhibition of several 
particular steps might selectively kill cancer 
cells. Godovac-Zimmermann explains her 
group’s initial contribution: “We investigated 
how these point observations were connected 
to wider aspects of cellular homeostasis”. 
She continues: “Unsurprisingly, we discovered 
that the point observations were parts of very 
complex, interacting functional networks that 
include processes distributed throughout the 
cell”. Now, her group are collaborating with cell 
and molecular biology groups to characterise 
these various networks.
Her team are also investigating factors which 
contribute to susceptibility to herpes simplex virus 
encephalitis: one of the most devastating infections 
of the central nervous system and particularly 
problematic for young children. In a similar way to 
the cancer investigation, this study began by taking 
point observations from other groups, in this case 
medicine, cell biology and genomic screening. 
They have already identiﬁ ed a number of new, 
unexpected proteins and pathways that provide 
new perspectives for further characterisation of the 
cause of the disease.
COLLABORATION FOR PROGRESS
Although there are new research tools which 
allow thousands of cellular components to be 
investigated, current systems biology tools tend 
to only provide fragments of understanding from 
the observed information. 
G o d o v a c-Z i m m e r m a n n 
explains a central problem: 
“At present, we seem to lack 
crucial basic concepts about 
the functioning of living 
systems that could greatly 
potentiate applications”.
By taking tools from a wide 
variety of disciplines – from 
biology to chemistry, physics, 
applied mathematics, 
computer science and 
beyond – proteomics 
aims to plug gaps in our 
knowledge and provide 
a deeper understanding 
than any single approach. 
Interdisciplinary research 
requires extensive 
collaboration, but Godovac-
Zimmerman believes this 
has been unduly limited: 
“It has been a mistake to 
treat proteomics groups as 
appendices to conventional 
biology groups”. If research is to advance, 
proteomics needs to be treated as a ﬁ eld in 
and of itself, where researchers from other 
disciplines can meet to solve some of the 
biggest questions.
DATA HARVESTING TO INTERPRETATION
Vast quantities of data have been produced 
which may provide answers to some of these 
questions. But the volume of data is becoming an 
increasing problem. Consequently, meta-analysis 
is increasingly seen as a vital tool for generating 
new concepts. However, the increasing volume 
of uncoordinated data may be a problem, as 
Godovac-Zimmermann elaborates: “So far we 
have not given sufﬁ cient attention to ensuring 
that the input data is coherent and that the 
resulting databases are reliable and relevant, 
both of which are essential for large-scale 
‘-omics’ science”. 
In fact, the incorporation of all this fragmented 
information into current systems biology tools 
could even be making the situation worse. 
Current ‘data harvesting’ tends to simply throw 
FIGURE 1. LOOKING FOR SPACE, TIME, QUANTITY, FORM AND DYNAMIC 
FLUXES IN HUMAN CELLS
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PROTEOMICS IN SYSTEMS BIOLOGY 
– DOES FORM, QUANTITY, LOCATION 
OR FLUX OF PROTEINS DOMINATE 
CELLULAR FUNCTION?
OBJECTIVES
Exploitation of the human genome in systems 
biology has tended to concentrate on the 
amounts of gene expression, although it is 
well known that over 50 per cent of eukaryotic 
genes generate multiple transcriptional variants 
and the majority of proteins are subject to 
various kinds of functionally important post-
translational modifi cations. We have established 
high throughput proteomics methods that 
can address at least some of the complexity in 
protein spatio-temporal distribution/fl ux in cells. 
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together snippets of information from all possible 
sources. This technique usually ignores the fact 
that there are many cases where the function 
of a protein in one cell type may not be the 
same as in another. As Godovac-Zimmermann 
elucidates: “In viral encephalitis we see strong 
cell variability between different patients at 
the individual protein level, but this is usually 
completely ignored and we do not yet have 
good ways of characterising the degree to which 
different patients have commonalities at a higher 
level of network responses. This might mean that 
enormous quantities of over-aggregated data 
in systems biology databanks actually obscure 
crucial information”.
STIFLING INNOVATION
Not only is the quantity of information a 
problem, there are also problems with quality 
and interpretation. Commercial attempts to 
provide meta-analysis tools suffer from lack 
of transparency with regard to input data 
and methods, from instability of the output 
databases and from severe constraints on 
how the data can be manipulated by users. 
Godovac-Zimmermann suggests it would be 
simpler if all of this information were held in 
the same place. “Unfortunately no institution 
has been given the responsibility of providing 
a public, well-organised, central repository of 
molecular information!” 
Even if data is plentiful and high quality, bias 
can creep into their interpretation, according 
to Godovac-Zimmermann: “New data tends to 
be ‘interpreted’ in terms of previously popular 
research areas. For example, we have seen 
indications in our project of the selective killing 
of cancer cells that overly facile assignment of 
observations to previously known functional 
networks may obscure the existence of parallel 
networks that may be complementary to, or 
competitors of, the better known networks”. 
There is a more fundamental problem facing 
systems biology researchers, and scientists in 
general: a change in the way that funding is 
allocated. The danger, particularly in publicly 
funded research, is that immediate commercial 
interests stifl e creativity and fundamental 
innovation. The pressure for short-term results 
of limited scope, defi ned in detail in advance, 
has become more and more of a prerequisite for 
scientifi c project proposals. However, Godovac-
Zimmermann believes that ‘good’ science will 
always fi nd a way to get through: “Truly creative 
scientists may ignore the stated goals and do 
what really interests them once they have the 
funding,” she concludes.
PROTEOMICS AND CELL BIOLOGY TEAM: M RADULOVIC, GH WILLIAMS, 
A QATTAN, M CRAWFORD, S TUDZAROVA AND K STOEBER
 The major future challenge for proteomics, biology and medicine is in 
elucidating how components interact in living systems
